2023-2029 Global HIV Antiretroviral Therapy Industry Research & Trends Analysis Report

Tables and Figures

Table 1. HIV Antiretroviral Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. HIV Antiretroviral Therapy Market Restraints
Table 3. HIV Antiretroviral Therapy Market Trends
Table 4. HIV Antiretroviral Therapy Industry Policy
Table 5. Global HIV Antiretroviral Therapy Revenue by Company (2018-2023) & (US$ million)
Table 6. Global HIV Antiretroviral Therapy Revenue Market Share by Company (2018-2023)
Table 7. Global HIV Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global HIV Antiretroviral Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global HIV Antiretroviral Therapy Manufacturers Product Type
Table 10. China HIV Antiretroviral Therapy Revenue by Company (2018-2023) & (US$ million)
Table 11. China HIV Antiretroviral Therapy Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of HIV Antiretroviral Therapy Upstream (Raw Materials)
Table 13. Global HIV Antiretroviral Therapy Typical Customers
Table 14. HIV Antiretroviral Therapy Typical Distributors
Table 15. By Type, Global HIV Antiretroviral Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global HIV Antiretroviral Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global HIV Antiretroviral Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million
Table 19. By Country, Global HIV Antiretroviral Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million
Table 21. By Country, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Table 22. Gilead Company Information, Head Office, Market Area and Industry Position
Table 23. Gilead Company Profile and Main Business
Table 24. Gilead HIV Antiretroviral Therapy Models, Specifications and Application
Table 25. Gilead HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 26. Gilead Recent Developments
Table 27. Roche Company Information, Head Office, Market Area and Industry Position
Table 28. Roche Company Profile and Main Business
Table 29. Roche HIV Antiretroviral Therapy Models, Specifications and Application
Table 30. Roche HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 31. Roche Recent Developments
Table 32. ViiV Healthcare Company Information, Head Office, Market Area and Industry Position
Table 33. ViiV Healthcare Company Profile and Main Business
Table 34. ViiV Healthcare HIV Antiretroviral Therapy Models, Specifications and Application
Table 35. ViiV Healthcare HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 36. ViiV Healthcare Recent Developments
Table 37. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 38. Boehringer Ingelheim Company Profile and Main Business
Table 39. Boehringer Ingelheim HIV Antiretroviral Therapy Models, Specifications and Application
Table 40. Boehringer Ingelheim HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 41. Boehringer Ingelheim Recent Developments
Table 42. Johnson and Johnson Company Information, Head Office, Market Area and Industry Position
Table 43. Johnson and Johnson Company Profile and Main Business
Table 44. Johnson and Johnson HIV Antiretroviral Therapy Models, Specifications and Application
Table 45. Johnson and Johnson HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 46. Johnson and Johnson Recent Developments
Table 47. Mylan Company Information, Head Office, Market Area and Industry Position
Table 48. Mylan Company Profile and Main Business
Table 49. Mylan HIV Antiretroviral Therapy Models, Specifications and Application
Table 50. Mylan HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 51. Mylan Recent Developments
Table 52. Bionor Pharma Company Information, Head Office, Market Area and Industry Position
Table 53. Bionor Pharma Company Profile and Main Business
Table 54. Bionor Pharma HIV Antiretroviral Therapy Models, Specifications and Application
Table 55. Bionor Pharma HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 56. Bionor Pharma Recent Developments
Table 57. Vertex Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 58. Vertex Pharmaceuticals Company Profile and Main Business
Table 59. Vertex Pharmaceuticals HIV Antiretroviral Therapy Models, Specifications and Application
Table 60. Vertex Pharmaceuticals HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 61. Vertex Pharmaceuticals Recent Developments
Table 62. Merck Company Information, Head Office, Market Area and Industry Position
Table 63. Merck Company Profile and Main Business
Table 64. Merck HIV Antiretroviral Therapy Models, Specifications and Application
Table 65. Merck HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 66. Merck Recent Developments
Table 67. CIPLA Company Information, Head Office, Market Area and Industry Position
Table 68. CIPLA Company Profile and Main Business
Table 69. CIPLA HIV Antiretroviral Therapy Models, Specifications and Application
Table 70. CIPLA HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 71. CIPLA Recent Developments
Table 72. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 73. AbbVie Company Profile and Main Business
Table 74. AbbVie HIV Antiretroviral Therapy Models, Specifications and Application
Table 75. AbbVie HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023
Table 76. AbbVie Recent Developments
List of Figure
Figure 1. HIV Antiretroviral Therapy Picture
Figure 2. Global HIV Antiretroviral Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China HIV Antiretroviral Therapy Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China HIV Antiretroviral Therapy Market Share of Global
Figure 5. Global HIV Antiretroviral Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global HIV Antiretroviral Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China HIV Antiretroviral Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China HIV Antiretroviral Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. HIV Antiretroviral Therapy Industry Chain
Figure 10. Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Figure 11. Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Figure 12. Protease Inhibitor (PI)
Figure 13. By Type, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 15. Hospital
Figure 16. Clinic
Figure 17. Other
Figure 18. By Application, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 20. By Region, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029
Figure 21. North America HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America HIV Antiretroviral Therapy Revenue Market Share, 2018-2023
Figure 23. Europe HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe HIV Antiretroviral Therapy Revenue Market Share, 2018-2023
Figure 25. Asia Pacific HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific HIV Antiretroviral Therapy Revenue Market Share, 2018-2023
Figure 27. South America HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America HIV Antiretroviral Therapy Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 32. By Type, U.S. HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 34. Europe HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 36. By Type, Europe HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 38. China HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 40. By Type, China HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 42. Japan HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 44. By Type, Japan HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 46. South Korea HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 48. By Type, South Korea HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 52. By Type, Southeast Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 54. India HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 56. By Type, India HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia HIV Antiretroviral Therapy Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches

Reason to Buy

• Current and future of Uncategorized Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Uncategorized Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets